Navigation Links
Cleveland researchers collaborate to launch Phase 1 clinical trial for new MS treatment
Date:8/23/2011

A team of researchers at three landmark Cleveland institutions have come together to launch a new clinical trial of an experimental treatment for multiple sclerosis (MS). Researchers at the Cleveland Clinic, University Hospitals Seidman Cancer Center, and Case Western Reserve University are collaborating on a ground-breaking study that will test the feasibility and safety of using the body's own stem cells to treat MS.

In patients with MS, the immune system abnormally attacks the central nervous system, causing damage to the nerve cells and their protective myelin sheath. The body has mechanisms that attempt to repair this damage; however, in MS, the repair cannot keep pace with the ongoing damage.

The Phase 1 trial involves harvesting a patient's mesenchymal stem cells (MSCs), which are primitive cells in the bone marrow, culturing them in a laboratory, and then injecting the MSCs intravenously back into the patient to see if the procedure is safe, decreases disease activity, and leads to improved repair.

The research team is headed up by Jeffrey Cohen, MD, of the Cleveland Clinic's Mellen Center for Multiple Sclerosis Treatment and Research, and is funded by a $2.75 million, four-year grant from the United States Department of Defense and a $1 million grant from the National Institutes of Health. Dr. Cohen is Director of the Mellen Center's Experimental Therapeutics Program and Professor of Medicine (Neurology) in the Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University School of Medicine. He has taken a lead role in a large number of MS clinical trials, including a Phase 3 trial that led to the recent approval of the first oral therapy for MS.

"Currently, there are eight medications approved to treat MS. They slow the disease but none of them reverses it. The hope is that mesenchymal stem cells will lessen ongoing damage caused by MS and promote repair," said Dr. Cohen. "We're taking a ca
'/>"/>

Contact: George Stamatis
george.stamatis@uhhospitals.org
216-844-3667
University Hospitals Case Medical Center
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Radiation from Japan detected in Cleveland
2. Cleveland Clinic researchers honored for contributions to science and technology
3. Draft sequence of Neandertal genome wins the 2010 AAAS Newcomb Cleveland Prize, supported by Affymetrix
4. Cleveland Museum of Natural History scientist announces new horned dinosaur
5. Cleveland Clinic, CWRU dental researcher finds switch that turns on the spread of cancer
6. UT researchers develop algorithm to improve remote electrocardiography
7. TGen and DTU researchers track source of Haitian cholera outbreak
8. UH researchers explore treatments for breast and colon cancers
9. Not so fast -- researchers find that lasting evolutionary change takes about 1 million years
10. Joslin researchers identify new target for treatment of type 2 diabetes and prediabetes
11. Southampton researchers awarded $28 million to progress pioneering nutrition and respiratory research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... The planet,s current biodiversity, the product of 3.5 billion ... in the history of life. But it may be ... of scientific literature and analysis of data published in ... that the loss and decline of animals is contributing ... the planet,s sixth mass biological extinction event. , Since ...
(Date:7/24/2014)... Einstein College of Medicine of Yeshiva University have ... for Parkinson,s Research to translate a basic science finding ... project will test chemical compounds on a newly identified ... acts on an underlying cause of the disease. ... manage their symptoms, we are eager to stop or ...
(Date:7/24/2014)... hotspot of biodiversity and one of the most species ... the world. However, current levels of diversity might be ... an increase in the description of new endemic species ... techniques and availability of samples for DNA analysis. ... molecular and morphological analysis, researchers from the University ...
Breaking Biology News(10 mins):Stanford biologist warns of early stages of Earth's 6th mass extinction event 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 3Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 3A tiny new species of frog from Brazil with a heroic name 2
... WAVCIS Program and also of the Coastal Studies Institute in ... published estimates that more than 75 percent of the oil ... participated in a three-hour flyover of the affected area in ... visible from overhead. "It,s most definitely there," said Stone. ...
... Congress to take legislative action that will allow federal ... in light of U.S. District Judge Royce Lamberth,s refusal ... research using embryonic stem cells. Research!America strongly ... introduced in March 2010 by Representatives Diana DeGette (D-CO) ...
... The potential for outbreaks of spruce and mountain ... to increase significantly in the coming decades, according to ... their colleagues. Their findings, published in the September issue ... comprehensive synthesis of the effects of climate change on ...
Cached Biology News:LSU's WAVCIS director says oil remains below surface, will come ashore in pulses 2Research!America asks Congress to support embryonic stem cell research now 2Risk of beetle outbreaks rise, along with temperature, in the warming West 2
(Date:7/24/2014)... DUBLIN , July 24, 2014 ... the "Global Cell Culture Market 2014-2018" report ... Cell culture is the in vitro ... such as research, cell studies, and biopharmaceutical production. Cell ... vaccine production. Cell culture instruments and cell culture consumables ...
(Date:7/24/2014)... PARK, Calif. , July 24, 2014 ... seven-year contract with the National Institute of Allergy and ... Health, to conduct preclinical development of potential therapies for ... of drugs to treat HIV and AIDS and the ... well as microbicides for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 2014 ... Sulphate Industry” is a professional and in-depth research ... introduces Potassium Sulphate basic information, including its ... industry overview. This research covers the international market ... global industry analysis covering macroeconomic environment & economic ...
(Date:7/24/2014)... 1000 balances – 4 steps – ... weighing needs and expertly narrows down the mass of ... or even terminals. , First, select the working ... select readability instead) and define the accuracy – it’s ... narrows down the list to models that fit best ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4
... Oct. 6 NEXCORE Technology, Inc., a,world-class original ... agreement with GI Supply of Camp Hill, Pa, ... Polar Wand is a portable,device that uses endoscopic ... gastrointestinal tract in patients resistant to conventional,endoscopic therapy., ...
... that it has been awarded a $12.9 million contract ... a part of the US,National Institutes of Health, to ... biomarkers., Under the contract to be performed over ... NIAID Clinical Proteomics Centers for Infectious,Disease & Biodefense, and ...
... REYKJAVIK, Iceland, Oct. 6 deCODE genetics,(Nasdaq: DCGN ... received a,notice from the Nasdaq Stock Market stating that ... common stock had been below $50 million,the minimum level ... set forth in Nasdaq Marketplace Rule 4450(b)(1)(A). The notice,further ...
Cached Biology Technology:NEXCORE Technology Selected to Manufacture New Endoscopic Cryotherapy Device 2Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract 2deCODE Receives Nasdaq Deficiency Notice Relating to Market Value 2deCODE Receives Nasdaq Deficiency Notice Relating to Market Value 3
...
Request Info...
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
Adducin beta (C-16)...
Biology Products: